What Artera Reported About the Atlantic Health Colonoscopy Outreach
Artera said on 30 March 2026 that Atlantic Health, a not-for-profit system serving New Jersey, Pennsylvania and the New York metropolitan area, deployed its AI agents for colonoscopy outreach to lift screening rates. Reporting Atlantic Health's own data from the first 30 days after launch, it says 43 percent of patients contacted by the AI agent answered the call and confirmed their identity, 39 percent confirmed they would attend their upcoming colonoscopy, 7 percent asked the agent questions about the procedure, and the agent reduced time spent on these calls by 38 percent.
Why the Artera and Atlantic Health Results Matter to Screening Programs
The figure most vendors would lead with is the time saving, but the more interesting one is that 7 percent of patients asked the agent a question about the procedure. Colonoscopy preparation confusion is a real reason people skip the appointment, so an agent that answers questions is doing more than confirming a slot. A 43 percent answer rate also means most calls did not connect, which is normal for outbound health calls and is the number a program should plan staffing around. These are Atlantic Health's results over 30 days at one system, not a general rate.
Where the Artera Update Comes From
Artera is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.
How We Would Research the Artera Atlantic Health Results
The source gives us the starting point. This is how we would build the next layer of research around it.
- We would ask Atlantic Health whether the actual colonoscopy completion rate moved, not just the confirmation rate.
- Then we would ask what the agent did with the 7 percent who asked questions and how often it handed off to a person.
- We would ask for the answer rate by time of day and language, since a 43 percent connect rate hides large differences between patient groups.